Mirati Therapeutics Appoints Industry Veteran Carol Gallagher, Pharm.D. as New Independent Director ...Middle East

SAN DIEGO, June 23, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced its Board of Directors has appointed a new independent director, Dr. Carol Gallagher. "I am pleased to welcome Dr. Gallagher to our Board during...

Hence then, the article about mirati therapeutics appoints industry veteran carol gallagher pharm d as new independent director was published today ( Friday 23/06/2023 - 11:04 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mirati Therapeutics Appoints Industry Veteran Carol Gallagher, Pharm.D. as New Independent Director )

Also on site :

• LA28 ticket registration nears deadline as first Olympic qualifiers emerge
• En medio de la crisis, el Gobierno de Cuba anuncia reformas económicas aunque persisten los obstáculos
• ‘American Idol' 2026: Who Went Home Tonight and Who Made It Through to the Top 14?